货号:GS40712
Teprotumumab is a fully human monoclonal antibody targeting insulin-like growth factor-1 receptor (IGF-1R). It blocks IGF-1R signaling, a pathway implicated in inflammation and tissue remodeling. It is approved for the treatment of Thyroid Eye Disease (TED), reducing proptosis (eye bulging), diplopia (double vision), and inflammation.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物